115.35USD+0.25%Mkt Cap: 6.49B USDP/E: 126.47Last update: 2026-05-26
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fib…
Industry Peers
Medical Instruments & SuppliesIndicators:|
Key Statistics
Company
Market Cap6.49B USD
Enterprise Value6.30B USD
Revenue (TTM)763.34M USD
Gross Profit386.25M USD
Net Income (TTM)48.89M USD
Revenue/Share13.56 USD
Last Price115.35 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.0K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINUS7599161095
Valuation
P/E (Trailing)126.47
P/E (Forward)44.42
PEG1.76
EV/EBITDA46.92
EV/Revenue8.25
P/S8.38
P/B3.04
EPS (TTM)0.91
EPS (Forward)2.55
52W Range
100.9919% of range175.77
52W High175.77 USD
52W Low100.99 USD
Profitability
Gross Margin52.32%
Oper. Margin8.90%
EBITDA Margin17.59%
Profit Margin6.62%
ROE2.32%
ROA1.66%
Growth
Revenue Growth14.80%
Earnings Growth47.90%
Cash Flow & Leverage
Operating CF117.42M USD
CapEx (TTM)25.73M USD
FCF Margin9.00%
FCF Yield1.06%
Net Debt-96.91M USD
Net Debt/EBITDA-0.72
Balance Sheet
Debt/Equity0.33
Current Ratio9.20
Quick Ratio7.45
Book Value/Sh37.33 USD
Cash/Share13.91 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)178.74 USD
Target Range142.00 USD – 220.00 USD
# Analysts19
Ownership
Shares Out.56.41M
Float53.37M
Insiders5.25%
Institutions119.46%
Short Interest
Short Ratio5.7d
Short % Float9.78%
Short % Out.9.76%
Shares Short5.50M
Short (prev mo.)5.56M
Technical
SMA 50117.79 (-2.1%)
SMA 200137.72 (-16.2%)
Beta1.09
S&P 52W Chg28.31%
Avg Vol (30d)1.27M
Avg Vol (10d)1.58M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—